How healthy young people will derive little benefit from a fourth or fifth dose of vaccine, and how we should keep them for the vulnerable population, and China's response to the COVID surge being of global interest and concern
The pros and cons of a 5th jab for health workers, whether we have reached the end of the road with mRNA-based vaccines, cutting through the subvariant hype, new vaccines on the horizon, and the 2023 forecast - does ATAGI need a rethink?
Entering a new wave driven by a soup of Omicron sub-variants, where more than 5 million Australians eligible for boosters have not received them, and how we must encourage patients to get their boosters, with the bivalent vaccines being more effective
The new COVID wave comprising of BQ1, XBB and other variants, and what our frontline response should look like, whether a fifth booster is worth having, children's vaccination developments and an update on the antivirals
How resources are being diverted to COVID-19, and how they have been affecting Tuberculosis resources, knowing when to suspect and diagnose active Tuberculosis and how to manage the patient
Despite a panoramic study suggesting a lower effect, Lagevrio has a useful impact on hospitalisations, deaths and shorter recovery time. Additionally COVID trials becoming more difficult to run because so many people have either been vaccinated and / or exposed
The elimination of isolation periods and mask mandates, and an update on the vaccination landscape, including recently approved jabs, the bivalent vaccine, and vaccination for children
Navigating interactions... it’s easier than it first looks, and how antivirals are an important part of the management strategy to reduce the chances of severe illness and hospital admissions
The Omicron booster, latest ATAGI decisions including the Moderna baby dose and Novavax for teens. Plus the new variant vaccines, should we mix and match boosters?